FR2432313A1 - Nouvelle forme galenique de la betahistine et son procede d'obtention - Google Patents

Nouvelle forme galenique de la betahistine et son procede d'obtention

Info

Publication number
FR2432313A1
FR2432313A1 FR7822665A FR7822665A FR2432313A1 FR 2432313 A1 FR2432313 A1 FR 2432313A1 FR 7822665 A FR7822665 A FR 7822665A FR 7822665 A FR7822665 A FR 7822665A FR 2432313 A1 FR2432313 A1 FR 2432313A1
Authority
FR
France
Prior art keywords
syndrome
controlled release
contg
treating
menieres
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7822665A
Other languages
English (en)
Other versions
FR2432313B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7822665A priority Critical patent/FR2432313A1/fr
Publication of FR2432313A1 publication Critical patent/FR2432313A1/fr
Application granted granted Critical
Publication of FR2432313B1 publication Critical patent/FR2432313B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette nouvelle forme est remarquable en ce qu'elle comprend une âme neutre, une première couche comprenant la bétahistine et/ou ses dérivés, puis une seconde couche extérieure constituée par une enveloppe microporeuse. Application à l'obtention de médicaments à effet prolongé.
FR7822665A 1978-08-01 1978-08-01 Nouvelle forme galenique de la betahistine et son procede d'obtention Granted FR2432313A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7822665A FR2432313A1 (fr) 1978-08-01 1978-08-01 Nouvelle forme galenique de la betahistine et son procede d'obtention

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7822665A FR2432313A1 (fr) 1978-08-01 1978-08-01 Nouvelle forme galenique de la betahistine et son procede d'obtention

Publications (2)

Publication Number Publication Date
FR2432313A1 true FR2432313A1 (fr) 1980-02-29
FR2432313B1 FR2432313B1 (fr) 1984-07-06

Family

ID=9211429

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7822665A Granted FR2432313A1 (fr) 1978-08-01 1978-08-01 Nouvelle forme galenique de la betahistine et son procede d'obtention

Country Status (1)

Country Link
FR (1) FR2432313A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982001468A1 (fr) * 1980-10-28 1982-05-13 Claude Laruelle Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2494112A1 (fr) * 1980-11-19 1982-05-21 Laruelle Claude
EP0061217A2 (fr) * 1981-03-19 1982-09-29 PHARMATEC S.p.A. Composition pharmaceutique à effet de retard contenant de l'ibuprofen
EP0202051A2 (fr) * 1985-05-06 1986-11-20 American Home Products Corporation Compositions thérapeutiques pour administration orale
WO2000053162A1 (fr) * 1999-03-05 2000-09-14 Farmaceutici Formenti S.P.A. Compositions de bétahistine à libération prolongée
EP1493435A1 (fr) * 2003-07-04 2005-01-05 FARMACEUTICI FORMENTI S.p.A. Compositions de bétahistine avec libération contrôlée
US8642631B2 (en) 2008-05-27 2014-02-04 University Of Melbourne Methods of treating mammals with eustachian tube dysfunctions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
AU433694B2 (en) * 1969-05-05 1973-03-13 Unimed Inc METHOD OF IMPROVING MICROCIRCULATION AND TREATING SENILITY. Application No. 16, 910/70 was lodged onthe 29th June 1970 asan additional ofthis application)
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
FR2353285A1 (fr) * 1975-09-17 1977-12-30 Doms Laboratoires Medicament vasodilatateur coronarien perfectionne

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
AU433694B2 (en) * 1969-05-05 1973-03-13 Unimed Inc METHOD OF IMPROVING MICROCIRCULATION AND TREATING SENILITY. Application No. 16, 910/70 was lodged onthe 29th June 1970 asan additional ofthis application)
FR2353285A1 (fr) * 1975-09-17 1977-12-30 Doms Laboratoires Medicament vasodilatateur coronarien perfectionne
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57502121A (fr) * 1980-10-28 1982-12-02
WO1982001468A1 (fr) * 1980-10-28 1982-05-13 Claude Laruelle Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
AT387517B (de) * 1980-11-19 1989-02-10 Claude Laruelle Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten
FR2494112A1 (fr) * 1980-11-19 1982-05-21 Laruelle Claude
WO1982001649A1 (fr) * 1980-11-19 1982-05-27 Laruelle Claude Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament
DE3152519C2 (de) * 1980-11-19 1990-11-22 Claude Laruelle Neues Fenofibrat-Fertigpr{parat mit verz¦gerter Wirkstofffreisetzung
EP0061217A3 (fr) * 1981-03-19 1983-04-20 PHARMATEC S.p.A. Composition pharmaceutique à effet de retard contenant de l'ibuprofen
EP0061217A2 (fr) * 1981-03-19 1982-09-29 PHARMATEC S.p.A. Composition pharmaceutique à effet de retard contenant de l'ibuprofen
EP0202051A2 (fr) * 1985-05-06 1986-11-20 American Home Products Corporation Compositions thérapeutiques pour administration orale
EP0202051A3 (en) * 1985-05-06 1987-08-19 American Home Products Corporation Therapeutic compositions for oral administration
WO2000053162A1 (fr) * 1999-03-05 2000-09-14 Farmaceutici Formenti S.P.A. Compositions de bétahistine à libération prolongée
CZ299510B6 (cs) * 1999-03-05 2008-08-20 Farmaceutici Formenti S. P. A. Tableta
EP1493435A1 (fr) * 2003-07-04 2005-01-05 FARMACEUTICI FORMENTI S.p.A. Compositions de bétahistine avec libération contrôlée
WO2005004850A1 (fr) * 2003-07-04 2005-01-20 Farmaceutici Formenti S.P.A. Compositions a liberation controlee de betahistine
EA011569B1 (ru) * 2003-07-04 2009-04-28 ФАРМАЧЕУТИЧИ ФОРМЕНТИ С.п.А. Таблетка с контролируемым высвобождением бетагистина
US8642631B2 (en) 2008-05-27 2014-02-04 University Of Melbourne Methods of treating mammals with eustachian tube dysfunctions

Also Published As

Publication number Publication date
FR2432313B1 (fr) 1984-07-06

Similar Documents

Publication Publication Date Title
NO178136C (no) Framgangsmåte for framstilling av et preparat for styrt frigjöring av en farmasöytisk aktiv substans
NO171506C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater
NO174952C (no) Fremgangsmåte ved fremstilling av et oralt, farmasöytisk preparat som er stabilt mot misfarging og som inneholder en syrelabil forbindelse
NO167572C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt purinderivat.
FR2432313A1 (fr) Nouvelle forme galenique de la betahistine et son procede d'obtention
NO167805C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive estere av 9-(2-hydroksyetoksymetyl)guanin.
HK1000093A1 (en) Dextrorotary enantiomer of alpha-(4,5,6,7-tetrahydrothienod3,2-capyrid-5-yl)(2-chlorophenyl)methyl acetate process for its preparation and pharmaceutical c
NZ182811A (en) Orally administrable pharmaceutical granules:coating layer of penicillin
BE870722A (nl) Werkwijze voor het vervaardigen van een kunstdarm van geregenereerde cellulose en van een bekledingspreparaat daarvoor
GR880100258A (en) Preparation method of a mould for the retarded liberating of impuprofene
DE69210124D1 (de) Geschmackabdeckende Beschichtung zur Herstellung kaubarer Arzneitabletten
IT1204294B (it) Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
EP0061217A3 (fr) Composition pharmaceutique à effet de retard contenant de l'ibuprofen
FR2313915A1 (fr) Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
NO147560C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanyl-derivater
MY103455A (en) Chewable medicament tablet containing means for taste masking
NO153099C (no) Analogifremgangsmaate for fremstilling av en terapeutisk virksom 5,5`-azobis-salicylsyre-forbindelse
ZA200006768B (en) Multiparticulate pharmaceutical form with programmed and timed release and preparation method.
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
NZ223343A (en) Dry formulations for the preparation of aqueous stable suspension for the parental administration of o-(2,6-dichloroanilino)phenylacetic acid (diclofenac)
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
GR3004863T3 (fr)
NO160133C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-(halobenzoyl)-methylfenyleddiksyrer, estere og salter derav.
NO176180C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-karbonyl-substituerte N,N-di(trimetoksybenzoyl) piperanziner
FR2453642A1 (fr) Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine

Legal Events

Date Code Title Description
TP Transmission of property
GC Lien (pledge) constituted
GC Lien (pledge) constituted